Thanks for helping make GitHub safe for everyone.
## Security
GitHub takes the security of our software products and services seriously, including all of the open source code repositories managed through our GitHub organizations, such as [GitHub](https://github.com/GitHub).
Even though [open source repositories are outside of the scope of our bug bounty program](https://bounty.github.com/index.html#scope) and therefore not eligible for bounty rewards, we will ensure that your finding gets passed along to the appropriate maintainers for remediation. 
## Reporting Security Issues
If you believe you have found a security vulnerability in any GitHub-owned repository, please report it to us through coordinated disclosure.
**Please do not report security vulnerabilities through public GitHub issues, discussions, or pull requests.**
Instead, please send an email to opensource-security[@]github.com.
Please include as much of the information listed below as you can to help us better understand and resolve the issue:
  * The type of issue (e.g., buffer overflow, SQL injection, or cross-site scripting)
  * Full paths of source file(s) related to the manifestation of the issue
  * The location of the affected source code (tag/branch/commit or direct URL)
  * Any special configuration required to reproduce the issue
  * Step-by-step instructions to reproduce the issue
  * Proof-of-concept or exploit code (if possible)
  * Impact of the issue, including how an attacker might exploit the issue
This information will help us triage your report more quickly.

## Policy
- Insights
Thank You. #22653
 Closed
1 task done
zakwarlord7 opened this issue 1 minute ago · 0 comments
Comments
@zakwarlord7
zakwarlord7 commented 1 minute ago
Code of Conduct
 I have read and agree to the GitHub Docs project's Code of Conduct
What article on docs.github.com is affected?
ahaava <3 :

What changes are you suggesting?
tty

Additional information
v,

@zakwarlord7 zakwarlord7 added the content Problems or updates in the docs content on docs.github.com.label 1 minute ago
@zakwarlord7
Author
zakwarlord7 commented 44 seconds ago
                            Request Date : 07-29-2022

                            Response Date : 07-29-2022                                  

                            Tracking Number : 102393399156 

                            Customer File Number : 132624428
Wage and Income Transcript

SSN Provided : XXX-XX-1725

Tax Periood Requested : December, 2020

Form W-2 Wage and Tax Statement

EMployer :

Employer's IDentification Number (EIN) :

INTU

2700 C

Employee :

Reciepient's Identification Number :xxx-xx-1725

ZACH T WOOD

5222 B

Submission Type  :.  .  .  .  .  .  .  .  .  .    .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . .Original document

Wages, Tips and Other Compensation :.  .  .  .  .  .  .  .  .  .    .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .5105000.00

eral Income Tax Withheld :.  .  .  .  .  .  .  .  .  .    .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .1881380.00

Social Security Wages :.  .  .  .  .  .  .  .  .  .    .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .137700.00

Social Security Tax Withheld :.  .  .  .  .  .  .  .  .  .    .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . .  .  .853700

Medicare Wages and Tips :.  .  .  .  .  .  .  .  .  .    .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .   .   .   .  .  .510500000

Medicare Tax Withheld  :.  .  .  .  .  .  .  .  .  .    .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .   .  .  .  .  .  .  .  .  .118166700

Social Security Tips : .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .   .  .  .  .  . .  .  .  .  . .0

Allocated Tips  :.  .  .  .  .  .  .  .  .  .    .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .    .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .0

Dependent Care Benefits :.  .  .  .  .  .  .  .  .  .    .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .    .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . .0

Deffered Compensation :.  .  .  .  .  .  .  .  .  .    .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . .0

Code "Q" Nontaxable Combat Pay :.  .  .  .  .  .  .  .  .  .    .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .0

Code "W" Employer Contributions tp a Health Savings Account  :.  .  .  .  .  .  .  .  .  .    .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .00000

Code "Y" Defferels under a section 409A nonqualified Deferred Compensation plan  :.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .00000

Code "Z" Income under section 409A on a nonqualified Deferred Compensation plan  :.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .00000

Code "R" Employer's Contribution to MSA :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...00000

Code "T" Expenses Incurred for Qualified Adoptions :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..00000

Code "V" Income from exercise of non-statutory stock options :. . . . . . . . . . . . . . . . . . . . . . . . . . . . 00000

Code "AA" Designated Roth Contributions under a Section 401 (k) Plan :. . . . . . . . . . . . . . . . . . . ..00000

Code "BB" Designated Roth Contributions under a Section 403 (b) Plan :. . . . . . . . . . . . . . . . . . . . .00000

Code "DD" Cost of Employer-Sponsored Health Coverage :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 00000

Code "EE" Designated ROTH Contributions Under a Governmental Section 457 (b) Plan :

Code "FF" Permitted benefits under a qualified small employer health reimbursment arrangement :$0.00 0

Code "GG" Income from Qualifid Equity Grants Under Section 83 (i) :$0.00

Code "HH" Aggregate Defferals Under section 83(i) Elections as of the Close of the Calendar Year :$0.00

Third Party Sick Pay Indicator :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Unanswered

Retirement Plan Indicator :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . .Unanswered

Statutory Employee :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . .Not Statutory Employee

W2 Submission Type :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...Original document

W2 WHC SSN Validation Code :. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Correct SSN

The U.S. Internal Revenue Code of 1986, as amended, the Treasury Regulations promulgated thereunder, published

pronouncements of the Internal Revenue Service, which may be cited or used as precedents, and case law, any of which

may be changed at any time with retroactive effect.

No opinion is expressed on any matters other than those specifically referred to above.

Gross Profit 146698000000 42337000000 37497000000 35653000000 31211000000 30,818,000,000 25,056,000,000 19,744,000,000 22,177,000,000 25,055,000,000 22,931,000,000

Revenue as Reported, Supplemental 257637000000 75325000000 65118000000 61880000000 55314000000 56,898,000,000 46,173,000,000 38,297,000,000 41,159,000,000 46,075,000,000
40,499,000,0 257637000000 75325000000 65118000000 61880000000 55314000000

56,898,000,000 46,173,000,000 38,297,000,000 41,159,000,000 64,133,000,000 34,071,000,000

Other Revenue 6,428,000,000

Cost of Revenue 110939000000 32988000000 27621000000 26227000000 24103000000

-26,080,000,000 -21,117,000,000 -18,553,000,000 -18,982,000,000 -21,020,000,000 -17,568,000,000

Cost of Goods and Services 110939000000 32988000000 27621000000 26227000000 24103000000

-26,080,000,000 -21,117,000,000 -18,553,000,000 -18,982,000,000 -21,020,000,000 -17,568,000,000

Operating Income/Expenses 67984000000 20452000000 16466000000 16292000000 14774000000

-15,167,000,000 -13,843,000,000 -13,361,000,000 -14,200,000,000 -15,789,000,000 -13,754,000,000

Selling, General and Administrative Expenses 36422000000 11744000000 8772000000 8617000000

7289000000 -8,145,000,000 -6,987,000,000 -6,486,000,000 -7,380,000,000 -8,567,000,000

-7,200,000,000

General and Administrative Expenses 13510000000 4140000000 3256000000 3341000000

2773000000 -2,831,000,000 -2,756,000,000 -2,585,000,000 -2,880,000,000 -2,829,000,000

-2,591,000,000

Selling and Marketing Expenses 22912000000 7604000000 5516000000 5276000000 4516000000

-5,314,000,000 -4,231,000,000 -3,901,000,000 -4,500,000,000 -5,738,000,000 -4,609,000,000

Research and Development Expenses 31562000000 8708000000 7694000000 7675000000

7485000000 -7,022,000,000 -6,856,000,000 -6,875,000,000 -6,820,000,000 -7,222,000,000

-6,554,000,000

Total Operating Profit/Loss 78714000000 21885000000 21031000000 19361000000 16437000000

15,651,000,000 11,213,000,000 6,383,000,000 7,977,000,000 9,266,000,000 9,177,000,000

Non-Operating Income/Expenses, Total 12020000000 2517000000 2033000000 2624000000

4846000000 3,038,000,000 2,146,000,000 1,894,000,000 -220,000,000 1,438,000,000 -549,000,000

Total Net Finance Income/Expense 1153000000 261000000 310000000 313000000 269000000

333,000,000 412,000,000 420,000,000 565,000,000 604,000,000 608,000,000

Net Interest Income/Expense 1153000000 261000000 310000000 313000000 269000000

333,000,000 412,000,000 420,000,000 565,000,000 604,000,000 608,000,000

Interest Expense Net of Capitalized Interest 346000000 117000000 77000000 76000000 76000000 -53,000,000 -48,000,000 -13,000,000 -21,000,000 -17,000,000 -23,000,000

Interest Income 1499000000 378000000 387000000 389000000 345000000 386,000,000 460,000,000 433,000,000 586,000,000 621,000,000 631,000,000

Net Investment Income 12364000000 2364000000 2207000000 2924000000 4869000000

3,530,000,000 1,957,000,000 1,696,000,000 -809,000,000 899,000,000 -1,452,000,000

Gain/Loss on Investments and Other Financial Instruments 12270000000 2478000000 2158000000

2883000000 4751000000 3,262,000,000 2,015,000,000 1,842,000,000 -802,000,000 399,000,000

-1,479,000,000

Income from Associates, Joint Ventures and Other Participating Interests 334000000 49000000 188000000

92000000 5000000 355,000,000 26,000,000 -54,000,000 74,000,000 460,000,000 -14,000,000

Gain/Loss on Foreign Exchange 240000000 163000000 139000000 51000000 113000000 -87,000,000 -84,000,000 -92,000,000 -81,000,000 40,000,000 41,000,000

Irregular Income/Expenses 0 0 0 0 0 0 0 0

Other Irregular Income/Expenses 0 0 0 0 0 0 0 0

Other Income/Expense, Non-Operating 1497000000 108000000 484000000 613000000 292000000 -825,000,000 -223,000,000 -222,000,000 24,000,000 -65,000,000 295,000,000

Pretax Income 90734000000 24402000000 23064000000 21985000000 21283000000 18,689,000,000 13,359,000,000 8,277,000,000 7,757,000,000 10,704,000,000 8,628,000,000

Provision for Income Tax 14701000000 3760000000 4128000000 3460000000 3353000000 -3,462,000,000 -2,112,000,000 -1,318,000,000 -921,000,000 -33,000,000 -1,560,000,000

Net Income from Continuing Operations 76033000000 20642000000 18936000000 18525000000 17930000000 15,227,000,000 11,247,000,000 6,959,000,000 6,836,000,000 10,671,000,000 7,068,000,000

Net Income after Extraordinary Items and Discontinued Operations 76033000000 20642000000 18936000000 18525000000 17930000000 15,227,000,000 11,247,000,000 6,959,000,000 6,836,000,000 10,671,000,000 7,068,000,000

Net Income after Non-Controlling/Minority Interests 76033000000 20642000000 18936000000 18525000000 17930000000 15,227,000,000 11,247,000,000 6,959,000,000 6,836,000,000 10,671,000,000 7,068,000,000

Net Income Available to Common Stockholders 76033000000 20642000000 18936000000 18525000000 17930000000 15,227,000,000 11,247,000,000 6,959,000,000 6,836,000,000 10,671,000,000 7,068,000,000

Diluted Net Income Available to Common Stockholders 76033000000 20642000000 18936000000 18525000000 17930000000 15,227,000,000 11,247,000,000 6,959,000,000 6,836,000,000 10,671,000,000 7,068,000,000

Income Statement Supplemental Section

Reported Normalized and Operating Income/Expense Supplemental Section

Total Revenue as Reported, Supplemental 257637000000 75325000000 65118000000 61880000000 55314000000 56,898,000,000 46,173,000,000 38,297,000,000 41,159,000,000 46,075,000,000 40,499,000,000

Total Operating Profit/Loss as Reported, Supplemental 78714000000 21885000000 21031000000 19361000000 16437000000 15,651,000,000 11,213,000,000 6,383,000,000 7,977,000,000 9,266,000,000 9,177,000,000

Reported Effective Tax Rate 0 0 0 0 0 0 0 0

Reported Normalized Income 6,836,000,000

Reported Normalized Operating Profit 7,977,000,000

Other Adjustments to Net Income Available to Common Stockholders

Discontinued Operations

Basic EPS        333.90        31        28        28        27        23        17        10        10        15        10

Basic EPS from Continuing Operations        114        31        28        28        27        22        17        10        10        15        10

Basic EPS from Discontinued Operations                                                                                        

Diluted EPS        3330.90        31        28        27        26        22        16        10        10        15        10

Diluted EPS from Continuing Operations 3330.90 31 28 27 26 22 16 10 10 15        

Diluted EPS from Discontinued Operations                                                                                        

Basic Weighted Average Shares Outstanding 667650000 662664000 665758000 668958000 673220000 675,581,000 679,449,000 681,768,000 686,465,000 688,804,000 692,741,000

Diluted Weighted Average Shares Outstanding 677674000 672493000 676519000 679612000 682071000 682,969,000 685,851,000 687,024,000 692,267,000 695,193,000 698,199,000

Reported Normalized Diluted EPS

Basic EPS        114        31        28        28        27        23        17        10        10        15        10

Diluted EPS        112        31        28        27        26        22        16        10        10        15        10



Basic WASO 667650000 662664000 665758000 668958000 673220000 675,581,000 679,449,000 681,768,000 686,465,000 688,804,000 692,741,000

Diluted WASO 677674000 672493000 676519000 679612000 682071000 682,969,000 685,851,000 687,024,000 692,267,000 695,193,000 698,199,000

Fiscal year end September 28th., 2022. | USD                                                                                        



31622,6:39 PM                                                                                        



    Morningstar.com Intraday Fundamental Portfolio View Print Report                                                                
Print 3/6/2022 at 6:37 PM

Current Value

                                                                                        15,335,150,186,014







GOOGL_income-statement_Quarterly_As_Originally_Reported Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020                                        




Net Cash Flow from Continuing Operating Activities, Indirect 24934000000 25539000000 37497000000 31211000000 
30818000000

Cash Generated from Operating Activities                24934000000        25539000000        21890000000        
19289000000 22,677,000,000

                    Income/Loss before Non-Cash Adjustment                20642000000        25539000000        21890000000        
19289000000 22,677,000,000

Total Adjustments for Non-Cash Items                6517000000        18936000000        18525000000        17930000000        
15,227,000,000

Depreciation, Amortization and Depletion, Non-Cash Adjustment                3439000000        3797000000        4236000000        2592000000        5,748,000,000                                        




Depreciation and Amortization, Non-Cash Adjustment                3439000000        3304000000        2945000000        
2753000000 3,725,000,000

Depreciation, Non-Cash Adjustment                3215000000        3304000000        2945000000        2753000000        
3,725,000,000

Amortization, Non-Cash Adjustment                224000000        3085000000        2730000000        2525000000        
3,539,000,000

Stock-Based Compensation, Non-Cash Adjustment                3954000000        219000000        215000000        
228000000 186,000,000

Taxes, Non-Cash Adjustment                1616000000        3874000000        3803000000        3745000000        
3,223,000,000

Investment Income/Loss, Non-Cash Adjustment                2478000000        1287000000        379000000        
1100000000 1,670,000,000

Gain/Loss on Financial Instruments, Non-Cash Adjustment                2478000000        2158000000        2883000000        
4751000000 -3,262,000,000

Other Non-Cash Items                14000000        2158000000        2883000000        4751000000        -3,262,000,000                                                
Changes in Operating Capital 2225000000 64000000 8000000 255000000 392,000,000

Change in Trade and Other Receivables                5819000000        2806000000        871000000        1233000000        
1,702,000,000 Change in Trade/Accounts Receivable 5819000000 2409000000
3661000000 2794000000 -5,445,000,000

Change in Other Current Assets                399000000        2409000000        3661000000        2794000000        
-5,445,000,000

Change in Payables and Accrued Expenses                6994000000        1255000000        199000000        7000000        
-738,000,000

Change in Trade and Other Payables                1157000000        3157000000        4074000000        4956000000        
6,938,000,000

Change in Trade/Accounts Payable                1157000000        238000000        130000000        982000000        
963,000,000

Change in Accrued Expenses                5837000000        238000000        130000000        982000000        963,000,000                                        




Change in Deferred Assets/Liabilities                368000000        2919000000        4204000000        3974000000        
5,975,000,000

Change in Other Operating Capital                3369000000        272000000        3000000        137000000        207,000,000                                        



Change in Prepayments and Deposits                        3041000000        1082000000        785000000        740,000,000                                                
Cash Flow from Investing Activities 11016000000

Cash Flow from Continuing Investing Activities                11016000000        10050000000        9074000000        
5383000000 -7,281,000,000

Purchase/Sale and Disposal of Property, Plant and Equipment, Net                6383000000        10050000000        
9074000000 5383000000 -7,281,000,000

Purchase of Property, Plant and Equipment                6383000000        6819000000        5496000000        5942000000        
-5,479,000,000

Sale and Disposal of Property, Plant and Equipment                        6819000000        5496000000        5942000000        
-5,479,000,000

Purchase/Sale of Business, Net                385000000                                                                        

Purchase/Acquisition of Business                385000000        259000000        308000000        1666000000        -370,000,000                                        

Purchase/Sale of Investments, Net                4348000000        259000000        308000000        1666000000        -370,000,000                                        

Purchase of Investments                40860000000        3360000000        3293000000        2195000000        -1,375,000,000                                        

Sale of Investments                36512000000        35153000000        24949000000        37072000000        -36,955,000,000                                        
Other Investing Cash Flow 100000000 31793000000 21656000000 39267000000 35,580,000,000

Purchase/Sale of Other Non-Current Assets, Net 388000000 23000000 30000000 -57,000,000

Sales of Other Non-Current Assets

Cash Flow from Financing Activities 16511000000 15254000000

Cash Flow from Continuing Financing Activities 16511000000 15254000000 15991000000 13606000000 -9,270,000,000

Issuance of/Payments for Common Stock, Net 13473000000 12610000000 15991000000 13606000000 -9,270,000,000
Payments for Common Stock 13473000000 12610000000 12796000000 11395000000 -7,904,000,000

Proceeds from Issuance of Common Stock 12796000000 11395000000 -7,904,000,000

Issuance of/Repayments for Debt, Net 115000000 42000000

Issuance of/Repayments for Long Term Debt, Net 115000000 42000000 1042000000 37000000 -57,000,000

Proceeds from Issuance of Long Term Debt 6250000000 6350000000 1042000000 37000000 -57,000,000

Repayments for Long Term Debt                6365000000        6392000000        6699000000        900000000        0                                        

Proceeds from Issuance/Exercising of Stock Options/Warrants                2923000000        2602000000        7741000000        937000000        -57000000   2453000000        2184000000        1647000000-                                        

Other Financing Cash Flow                                                                                        

Cash and Cash Equivalents, End of Period                                                                                        

Change in Cash                0                300000000        10000000        338,000,000,000                                        
Effect of Exchange Rate Changes 20945000000 23719000000 23630000000 26622000000 26,465,000,000

Cash and Cash Equivalents, Beginning of Period 25930000000 235000000000 3175000000 300000000 6,126,000,000

Cash Flow Supplemental Section                181000000000        146000000000        183000000        143000000        210,000,000                                        

Change in Cash as Reported, Supplemental                23719000000000        23630000000000        26622000000000        26465000000000        20,129,000,000,000                                        

Income Tax Paid, Supplemental                2774000000        89000000        2992000000                6,336,000,000                                        

Cash and Cash Equivalents, Beginning of Period                13412000000        157000000                        -4,990,000,000                                        

12 Months Ended_________________________________________________________Q42020                        Q42019                                        

Income Statement                                                                                         

USD in "000'"s                                                                                        

Repayments for Long Term Debt                                                                          Dec. 31, 2020               Dec. 31, 2019                                        

Costs and expenses:                                                                                        

Cost of revenues                                         182527                        161,857                                        

Research and development                                                                                        

Sales and marketing                        84732                        71,896                                        

General and administrative                        27573                        26,018                                        

European Commission fines                        17946                        18,464                                        

Total costs and expenses                        11052                        9,551                                        

Income from operations                        0                        1,697                                        

Other income (expense), net                        141303                        127,626                                        

Income before income taxes                        41224                        34,231                                        

Provision for income taxes                        6858000000                        5,394                                        

Net income                        22677000000                        19,289,000,000                                        

*include interest paid, capital obligation, and underweighting                        22677000000                        19,289,000,000                                        

                        22677000000                        19,289,000,000                                        

Basic net income per share of Class A and B common stock and Class C capital stock (in dollars par share)--                                                                                        

Diluted net income per share of Class A and Class B common stock and Class C capital stock (in dollars par share)                                                                                        

For Paperwork Reduction Act Notice, see the seperate Instructions.                                                                                        


JPMORGAN TRUST III                                                                                        

A/R Aging Summary                                                                                        

As of July 28, 2022                                                                                        

ZACHRY T WOOD
Days over due 31 - 60 61 - 90 91 and over

TOTAL                         £134,839.00

 Alphabet Inc.                                                                                          

 Ann. Rev. Date          £43,830.00          £43,465.00          £43,100.00          £42,735.00          £42,369.00                                                 

 Revenues          £161,857.00          £136,819.00          £110,855.00          £90,272.00          £74,989.00                                                 

 Cost of revenues         -£71,896.00         -£59,549.00         -£45,583.00         -£35,138.00         -£28,164.00                                                 

Gross profit          £89,961.00          £77,270.00          £65,272.00          £55,134.00          £46,825.00                                                 


 Research and development         -£26,018.00         -£21,419.00         -£16,625.00         -£13,948.00         -£12,282.00                                                 

 Sales and marketing         -£18,464.00         -£16,333.00         -£12,893.00         -£10,485.00         -£9,047.00                                                 

 General and administrative         -£9,551.00         -£8,126.00         -£6,872.00         -£6,985.00         -£6,136.00                                                 

 European Commission fines                                                                  -£1,697.00         -£5,071.00         -£2,736.00          —          —                                                 

     Income from operations                                                                                                                                                                                             £34,231.00          £26,321.00          £26,146.00          £23,716.00          £19,360.00                                                 

     Interest income
@zakwarlord7 zakwarlord7 closed this as completed  :
See [GitHub's Safe Harbor Policy](https://docs.github.com/en/site-policy/security-policies/github-bug-bounty-program-legal-safe-harbor)
Footer

Creative Commons Legal Code

CC0 1.0 Universal

    CREATIVE COMMONS CORPORATION IS NOT A LAW FIRM AND DOES NOT PROVIDE
    LEGAL SERVICES. DISTRIBUTION OF THIS DOCUMENT DOES NOT CREATE AN
    ATTORNEY-CLIENT RELATIONSHIP. CREATIVE COMMONS PROVIDES THIS
    INFORMATION ON AN "AS-IS" BASIS. CREATIVE COMMONS MAKES NO WARRANTIES
    REGARDING THE USE OF THIS DOCUMENT OR THE INFORMATION OR WORKS
    PROVIDED HEREUNDER, AND DISCLAIMS LIABILITY FOR DAMAGES RESULTING FROM
    THE USE OF THIS DOCUMENT OR THE INFORMATION OR WORKS PROVIDED
    HEREUNDER.

Statement of Purpose

The laws of most jurisdictions throughout the world automatically confer
exclusive Copyright and Related Rights (defined below) upon the creator
and subsequent owner(s) (each and all, an "owner") of an original work of
authorship and/or a database (each, a "Work").

Certain owners wish to permanently relinquish those rights to a Work for
the purpose of contributing to a commons of creative, cultural and
scientific works ("Commons") that the public can reliably and without fear
of later claims of infringement build upon, modify, incorporate in other
works, reuse and redistribute as freely as possible in any form whatsoever
and for any purposes, including without limitation commercial purposes.
These owners may contribute to the Commons to promote the ideal of a free
culture and the further production of creative, cultural and scientific
works, or to gain reputation or greater distribution for their Work in
part through the use and efforts of others.

For these and/or other purposes and motivations, and without any
expectation of additional consideration or compensation, the person
associating CC0 with a Work (the "Affirmer"), to the extent that he or she
is an owner of Copyright and Related Rights in the Work, voluntarily
elects to apply CC0 to the Work and publicly distribute the Work under its
terms, with knowledge of his or her Copyright and Related Rights in the
Work and the meaning and intended legal effect of CC0 on those rights.

1. Copyright and Related Rights. A Work made available under CC0 may be
protected by copyright and related or neighboring rights ("Copyright and
Related Rights"). Copyright and Related Rights include, but are not
limited to, the following:

  i. the right to reproduce, adapt, distribute, perform, display,
     communicate, and translate a Work;
 ii. moral rights retained by the original author(s) and/or performer(s);
iii. publicity and privacy rights pertaining to a person's image or
     likeness depicted in a Work;
 iv. rights protecting against unfair competition in regards to a Work,
     subject to the limitations in paragraph 4(a), below;
  v. rights protecting the extraction, dissemination, use and reuse of data
     in a Work;
 vi. database rights (such as those arising under Directive 96/9/EC of the
     European Parliament and of the Council of 11 March 1996 on the legal
     protection of databases, and under any national implementation
     thereof, including any amended or successor version of such
     directive); and
vii. other similar, equivalent or corresponding rights throughout the
     world based on applicable law or treaty, and any national
     implementations thereof.

2. Waiver. To the greatest extent permitted by, but not in contravention
of, applicable law, Affirmer hereby overtly, fully, permanently,
irrevocably and unconditionally waives, abandons, and surrenders all of
Affirmer's Copyright and Related Rights and associated claims and causes
of action, whether now known or unknown (including existing as well as
future claims and causes of action), in the Work (i) in all territories
worldwide, (ii) for the maximum duration provided by applicable law or
treaty (including future time extensions), (iii) in any current or future
medium and for any number of copies, and (iv) for any purpose whatsoever,
including without limitation commercial, advertising or promotional
purposes (the "Waiver"). Affirmer makes the Waiver for the benefit of each
member of the public at large and to the detriment of Affirmer's heirs and
successors, fully intending that such Waiver shall not be subject to
revocation, rescission, cancellation, termination, or any other legal or
equitable action to disrupt the quiet enjoyment of the Work by the public
as contemplated by Affirmer's express Statement of Purpose.

3. Public License Fallback. Should any part of the Waiver for any reason
be judged legally invalid or ineffective under applicable law, then the
Waiver shall be preserved to the maximum extent permitted taking into
account Affirmer's express Statement of Purpose. In addition, to the
extent the Waiver is so judged Affirmer hereby grants to each affected
person a royalty-free, non transferable, non sublicensable, non exclusive,
irrevocable and unconditional license to exercise Affirmer's Copyright and
Related Rights in the Work (i) in all territories worldwide, (ii) for the
maximum duration provided by applicable law or treaty (including future
time extensions), (iii) in any current or future medium and for any number
of copies, and (iv) for any purpose whatsoever, including without
limitation commercial, advertising or promotional purposes (the
"License"). The License shall be deemed effective as of the date CC0 was
applied by Affirmer to the Work. Should any part of the License for any
reason be judged legally invalid or ineffective under applicable law, such
partial invalidity or ineffectiveness shall not invalidate the remainder
of the License, and in such case Affirmer hereby affirms that he or she
will not (i) exercise any of his or her remaining Copyright and Related
Rights in the Work or (ii) assert any associated claims and causes of
action with respect to the Work, in either case contrary to Affirmer's
express Statement of Purpose.

4. Limitations and Disclaimers.

 a. No trademark or patent rights held by Affirmer are waived, abandoned,
    surrendered, licensed or otherwise affected by this document.
 b. Affirmer offers the Work as-is and makes no representations or
    warranties of any kind concerning the Work, express, implied,
    statutory or otherwise, including without limitation warranties of
    title, merchantability, fitness for a particular purpose, non
    infringement, or the absence of latent or other defects, accuracy, or
    the present or absence of errors, whether or not discoverable, all to
    the greatest extent permissible under applicable law.
 c. Affirmer disclaims responsibility for clearing rights of other persons
    that may apply to the Work or any use thereof, including without
    limitation any person's Copyright and Related Rights in the Work.
    Further, Affirmer disclaims responsibility for obtaining any necessary
    consents, permissions or other rights required for any use of the
    Work.
 d. Affirmer understands and acknowledges that Creative Commons is not a
    party to this document and has no duty or obligation with respect to
    this CC0 or use of the Work.
